Insmed inc (INSM)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
License fees

-

-

-

-

-

-

-

-

1,002

4

129

Other revenue

-

-

-

-

-

-

11,500

-

-

-

-

Grant revenue

-

-

-

-

-

-

-

-

-

-

1,044

Other expanded access program income, net

-

-

-

-

-

-

-

-

3,415

6,917

9,200

Revenues, net

136,467

9,835

0

0

0

-

11,500

-

4,417

6,921

10,373

Cost of product revenues (excluding amortization of intangible assets)

24,212

2,423

0

0

-

-

-

-

-

-

-

Gross profit

112,255

7,412

0

-

-

-

-

-

-

-

-

Operating expenses:
Research and development

131,711

145,283

109,749

122,721

74,277

56,292

44,279

29,781

28,623

4,702

9,207

Selling, general and administrative

210,796

168,218

79,171

50,679

43,216

31,073

22,236

12,657

11,523

10,311

9,840

Amortization of intangible assets

4,993

1,249

0

0

-

-

-

-

-

-

-

Total costs and expenses

347,500

314,750

188,920

173,400

117,493

87,365

66,515

42,438

66,136

15,013

19,047

Impairment loss

-

-

-

-

-

-

-

-

25,990

0

0

Operating loss

-235,245

-307,338

-188,920

-173,400

-117,493

-87,365

-55,015

-42,438

-61,719

-8,092

-8,674

Investment income

9,921

10,341

1,624

604

261

58

166

1,822

2,064

1,845

808

Interest expense

27,705

25,472

5,925

3,498

2,889

2,415

2,412

763

10

109

781

Loss on extinguishment of debt

0

-2,209

0

0

-

-

-

-

-

-

-

Other income (expense), net

-531

602

300

119

-33

141

-33

5

1

-

-

Loss before income taxes

-253,560

-324,076

-192,921

-176,175

-120,154

-89,581

-57,294

-41,374

-59,664

-6,356

118,827

Gain on sale of assets, net

-

-

-

-

-

-

-

-

-

0

127,474

Provision for income taxes

777

201

-272

98

-1,971

-10,422

-1,221

0

0

78

477

Net loss

-254,337

-324,277

-192,649

-176,273

-118,183

-79,159

-56,073

-41,374

-59,664

-6,434

118,350

Basic and diluted net loss per share (in dollars per share)

-3.01

-4.22

-2.89

-2.85

-2.02

-1.84

-1.60

-1.56

-2.95

-0.49

-

Weighted average basic and diluted common shares outstanding

84,560

76,889

66,576

61,892

58,633

43,095

34,980

26,545

23,348

13

12

Accretion of beneficial conversion charge

-

-

-

-

-

-

-

-

-9,175

0

0

Net loss

-254,337

-324,277

-192,649

-176,273

-118,183

-79,159

-

-41,374

-68,839

-6,434

118,350

Other comprehensive income (loss):
Foreign currency translation (losses) gains

-1

-6

62

-65

0

-

-

-

-

-

-

Net loss attributable to common stockholders

-254,337

-324,277

-192,649

-176,273

-118,183

-

-

-

-68,839

-6,434

118,350

Unrealized loss on investments, net of taxes

-

-

-

-

-

-

-

-450

-543

993

-

Total comprehensive loss

-254,338

-324,283

-192,587

-176,338

-118,183

-79,159

-

-41,824

-69,382

-5,441

-

Diluted net (loss) income attributable to common stockholders per common share (in dollars per share)

-

-

-

-

-

-

-

-

-

-

9.30

Weighted average diluted common shares outstanding (in shares)

-

-

-

-

-

-

-

-

-

13,250

12

Basic net (loss) income attributable to common stockholders per common share (in dollars per share)

-

-

-

-

-

-

-

-

-

-

9.31